Completed Infection & Immunity Lungs & Breathing

The cellular and molecular basis for the impact of vitamin A on immunity.

In plain English

AI plain-English summary

Vitamin A deficiency doesn't just cause blindness—it also cripples the immune system, and this project will uncover exactly how that happens at the molecular level. The problem is that while we know vitamin A is essential for immunity, the precise mechanism remains a black box. Retinoic acid, the active form of vitamin A, appears to control how white blood cells decide their identity and function. This project will map those decisions in living animals, tracking single immune cells as they respond to infection in vitamin A-replete versus deficient environments. By genetically switching off retinoic acid signalling in specific cell types, the researchers can establish direct cause-and-effect relationships between the vitamin, particular immune cells, and overall immune strength. This is fundamental science—it will not produce a drug or treatment tomorrow. But understanding how vitamin A programs immune cell differentiation could eventually inform therapies for autoimmune diseases, improve vaccine design, and explain why vitamin A supplementation reduces child mortality from infections. The same molecular pathways that govern immune cell fate also operate in cancer and transplant rejection, so the insights could ripple across multiple fields of medicine.

View original technical description
While blindness is an apparent consequence of vitamin A deficiency, incapacitation of the immune system is another devastating result. The studies presented investigate the role of retinoic A (RA) on the development of immunity. We hypothesize that RA exerts a profound impact on the lineage commitment of mature leukocytes. At a systems level, we study its essential role in the development of acquired immunity, and in the complex diseases of cancer, graft rejection and autoimmunity. At a cellular level, responding leukocytes will be studied in vivo at the single cell level, permitting the visualization of antigen-specific immunity in RA-replete or deficient environments. Through the conditional ablation of RA signaling, the RA responsiveness of defined leukocyte subsets will be genetically controlled in vivo, allowing us to define strict cause and effect relationships between RA signaling, specific cell type and overall immunity. A picture of the temporal and spatial synthesis of RA and RA signaling will emerge using engineered reporting mice . Finally, the genetic and epigenetic basis for how RA programs leukocyte differentiation will be determined. These studies span from the fundamental molecular regulation of the immune system by RA to the translational use of regulatory T cells to treat disease.

View the original record at the funder ↗

Researchers

Randolph Noelle (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

The role of retinoic acid in T-helper cell differentiation and lineage commitment.
Integrin-mediated regulation of leukocytes in autoimmunity
The role of Myeloid Inhibitory C-type lectin-like receptor (MICL, CLEC12A) in Rheumatoid Arthritis
Investigating the immune response to citrullinated antigen
The molecular and cellular basis of complement-mediated T helper 1 (TH1) differentiation and regulation

Original classification

Principal Research Fellowship (New)

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.